Mohammed Eslam (Mohammad Eslam)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Topics

Tyrosine Kinase

Helicobacter Pylori Infection

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Science translational medicine

Nature reviews. Gastroenterology & hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Mohamed Alboraie, Yasser Mahrous Fouad, Mohammed Eslam
Letter to the Editor: MAFLD versus MASLD-Which is more appropriate from a global perspective? Hepatology (Baltimore, Md.) (2024)
Mohammed Eslam, Rasha El Sharkway, Ali Bayoumi, Mayada Metwally, Brian S Gloss, Robert Brink, David Bo Lu, Christopher Liddle, Saleh A Alqahthani, Jun Yu, Philip J O'Connell, Jacob George, Mohammed Eslam
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease. Science translational medicine 16 (741) (2024)
Ziyan Pan, Yusuf Yilmaz, Said A Al-Busafi, Mohammed Eslam
The MAFLD definition identifies three homogenous groups of patients. Liver international : official journal of the International Association for the Study of the Liver (2024)
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Ziyan Pan, Mohammed Eslam
Bringing evidence to the MAFLD-MASLD debate. Liver international : official journal of the International Association for the Study of the Liver (2024)
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver (2024)
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Mohammed Eslam, Rasha El Sharkway, Ali Bayoumi, Mayada Metwally, Brian S Gloss, Robert Brink, David Bo Lu, Christopher Liddle, Saleh A Alqahthani, Jun Yu, Philip J O'Connell, Jacob George, Mohammed Eslam
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease. Science translational medicine 16 (741) (2024)
Ziyan Pan, Gamal Shiha, Gamal Esmat, Nahum Méndez-Sánchez, Mohammed Eslam
MAFLD predicts cardiovascular disease risk better than MASLD. Liver international : official journal of the International Association for the Study of the Liver (2024)
Ziyan Pan, Mohammed Eslam
Bringing evidence to the MAFLD-MASLD debate. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Ziyan Pan, Gamal Shiha, Gamal Esmat, Nahum Méndez-Sánchez, Mohammed Eslam
MAFLD predicts cardiovascular disease risk better than MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Ziyan Pan, Mohammed Eslam
Bringing evidence to the MAFLD-MASLD debate. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Ziyan Pan, Gamal Shiha, Nahum Méndez-Sánchez, Mohammed Eslam
Dual-aetiology MAFLD and metabolic dysfunction. Liver international : official journal of the International Association for the Study of the Liver (2024)
Mohammed Eslam, Rasha El Sharkway, Ali Bayoumi, Mayada Metwally, Brian S Gloss, Robert Brink, David Bo Lu, Christopher Liddle, Saleh A Alqahthani, Jun Yu, Philip J O'Connell, Jacob George, Mohammed Eslam
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease. Science translational medicine 16 (741) (2024)
Mohamed Alboraie, Yasser Mahrous Fouad, Mohammed Eslam
Letter to the Editor: MAFLD versus MASLD-Which is more appropriate from a global perspective? Hepatology (Baltimore, Md.) 80 (3) (2024)
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Mohamed Alboraie, Yasser Mahrous Fouad, Mohammed Eslam
Letter to the Editor: MAFLD versus MASLD-Which is more appropriate from a global perspective? Hepatology (Baltimore, Md.) 80 (3) (2024)
Ziyan Pan, Gamal Shiha, Gamal Esmat, Nahum Méndez-Sánchez, Mohammed Eslam
MAFLD predicts cardiovascular disease risk better than MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Jawaher Alharthi, Ali Bayoumi, Khaled Thabet, Ziyan Pan, Brian S Gloss, Olivier Latchoumanin, Mischa Lundberg, Natalie A Twine, Duncan McLeod, Shafi Alenizi, Leon A Adams, Martin Weltman, Thomas Berg, Christopher Liddle, Jacob George, Mohammed Eslam
A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes. Nature communications 13 (1) (2022)
Mohammed Eslam, Hashem E El-Serag, Sven M Francque, Shiv Kumar Sarin, Lai Wei, Elisabetta Bugianesi, Jacob George
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nature reviews. Gastroenterology & hepatology 19 (10) (2022)
Gamal Shiha, Reham Soliman, Nabiel Mikhail, Ayman Hassan, Mohammed Eslam
Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk-based surveillance using pre- and post-treatment general evaluation score. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)
Shahinul Alam, Mohammed Eslam, Nazmul Skm Hasan, Kamrul Anam, Mohammad Abdul Baker Chowdhury, Md Abdullah Saeed Khan, Mohammad Jahid Hasan, Rosmawati Mohamed
Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta-analysis. JGH open : an open access journal of gastroenterology and hepatology 5 (11) (2021)
Sakura Yamamura, Mohammed Eslam, Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Shinobu Yoshinaga, Hirokazu Takahashi, Keizo Anzai, Jacob George, Takuji Torimura
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver international : official journal of the International Association for the Study of the Liver 40 (12) (2021)
Stefania Grimaudo, Paola Dongiovanni, Jussi Pihlajamäki, Mohammed Eslam, Hannele Yki-Järvinen, Rosaria Maria Pipitone, Guido Baselli, Calogero Cammà, Vito Di Marco, Marco Enea, Miriam Longo, Grazia Pennisi, Daniele Prati, Rossella Zito, Anna Ludovica Fracanzani, Antonio Craxì, Jacob George, Stefano Romeo, Luca Vittorio Valenti, Salvatore Petta
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)
Gamal Shiha, Imam Waked, Reham Soliman, Mohamed Elbasiony, Asmaa I Gomaa, Nabiel N H Mikhail, Mohammed Eslam
GES: A validated simple score to predict the risk of HCC in patients with HCV-GT4-associated advanced liver fibrosis after oral antivirals. Liver international : official journal of the International Association for the Study of the Liver 40 (11) (2021)
Jawaher Alharthi, Mohammed Eslam
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update. Journal of clinical and translational hepatology 10 (1) (2021)
Gamal Shiha, Reham Soliman, Nabiel Mikhail, Mohammed Eslam
Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single-centre cohort of European cirrhotics. Liver international : official journal of the International Association for the Study of the Liver 41 (5) (2020)
Diana Julie Leeming, Signe Holm Nielsen, Roslyn Vongsuvanh, Pruthviraj Uchila, Mette Juul Nielsen, Alexander L Reese-Petersen, David van der Poorten, Mohammed Eslam, Detlef Schuppan, Morten Asser Karsdal, Jacob George
Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma. Hepatic oncology 8 (2) (2020)
Mohammed Eslam, Jacob George
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology. Nature reviews. Gastroenterology & hepatology 17 (1) (2019)